Accuray is a radiation therapy company that develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments. Co.'s technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, its TomoTherapy platform, are designed to deliver various treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Co. also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other services. The ARAY stock yearly return is shown above.
The yearly return on the ARAY stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2014 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ARAY annual return calculation with any dividends reinvested as applicable (on ex-dates).
|